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Murine class II MHC-restricted helper/inducer T lymphocytes can be divided
into at least two nonoverlapping subsets, based on patterns of lymphokine gene
transcription and secretion . One subset, provisionally called Thl, secretes IL-2
and IFN-y upon stimulation by antigen or lectin and uses IL-2 as its autocrine
growth factor . The other subset, called Th2, produced IL-4 and IL-5 and used
IL-4 as its growth factor (1-5) . Cloned lines representing Thl and Th2 cells also
vary in their proliferative responses to exogenous cytokines (6) . It has been pos-
tulated that these subsets perform fundamentally different functions, Thl cells
being primarily involved in cell-mediated immune responses, such as delayed
hypersensitivity, and Th2 cells in humoral immunity (7, 8) .
Studies aimed at analyzing the requirements for helper T cell-dependent anti-
body responses have produced contradictory results . Thus, both murine and
human B cells proliferate and differentiate in response to IL-2 and IFN-y (9-
11), and Thl clones have been reported to induce antibody responses as a result
of cognate interactions with B cells (12) . In contrast, more recent experiments
have emphasized the helper function of Th2 cells (13-15), and have even sug-
gested that only IL-4-producing T cells are capable of helping resting B lym-
phocytes (4) . A fundamental problem with such experiments is that they do not
include formal comparisons ofThl andTh2 cells of the same antigen specificity.
Moreover, these analyses do not take into account recent data indicating that
different lymphokines may be uniquely responsible for the production of differ-
ent antibody isotypes, e.g ., IL-4 for IgGI and IgE (16, 17), IL-5 for IgA (18),
and IFN-y for IgC,2a (17) .
In the present experiments, we have compared the ability of murine Thl and
Th2 clones to induce the proliferation and differentiation of resting B cells . The
system we have chosen involves isolation of B cells without an affinity purifica-
tion step in order to avoid possible activation . We have used, as a model antigen,
rabbit anti-mouse Ig and examined the ability of rabbit Ig-specific, la-restricted
T cell clones to help B cells (13, 14) . Such an experimental model resembles, to
the extent possible, the physiologic in vivo situation of cognate help mediated
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to different aspects of B cell activation, Our results establish striking differences
elner activity of these two T cell subsets, demonstrate an obligatory role
of IL-4 and IL-5 in the proliferation and differentiation of resting B cells, and
show that lPNTis both an inhibitor of B cell activation and the major or only
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Antigens, Cytokines, and Antibodies. F(ab')2 fragments of rabbit anti-mouse Ig
(RAMG)' were purchased from Cappel Laboratories, Malvern, PA. F(ab)2 fragments of
rabbit Ig (RGG) were made by pepsin digestion and purified by chromatography on pro-
tein A-Sepharose. These two reagents were used as the antigens in all experiments with
B cells. Rabbit Ig was purchased from Sigma Chemical Co., St. Louis, MO, and
used as antigen for weekly passage of T cell clones. fschenchia m6LPS was purchased
from Difco Laboratories, Detroit, MI.
86oriucrIL-4 (expressed ioyeast) *amgenerously provided by Dr. A.GiUi".l/omuocx
Corp., Seattle, WA. The activity of this preparation was determined at Immunex Corp.
uudexpressed inunits as defined (19). Murine and human rIL-2 were purchased from
Genzyme Corp., Boston, MA, and used according to units as defined by the supplier.
Murine rIFN-,y was generously given by Genentech, Inc., South San Francisco, CA. Con-
centrations are expressed as units defined by the supplier.
The neutralizing mAb for murine IL-4, I I B11, has been described (20) and was used
as a hybridoma culture supernatant at final dilutions of 1 : 10 to 1 :50. Anti-I L-2 antibody,
S4116, was a gift of Dr. T. Mosmann, DNAX, Palo Alto, CA, and was used at a 1 :20
dilution of an (NH4)2SO4 precipitated 20 X concentrate of hybridoma supernatant. Anti-
IL-5 antibody was a generous gift from Dr. K. Takatsu, Kumamoto University Medical
School, Kumamoto, Japan, and was used as an ascites fluid at a dilution of 1 : 1,000 to
1 :10,000 (21). The hamster anti-murine IFN--y mAb, H22.10.30.22, was the generous
gift of Dr. R. Schreiber, Washington University School of Medicine, St. Louis, MO (22).
The affinity-purified antibody was uged at concentrations of 0. 1 to 1.0 jug/ml. Additional
mAbs used for T cell depletion in the preparation of small resting B cells were anti-Thy~
L2 and antblyt-1 .2 (Nov England Nuclear, Boston, MA) and anti-Lyt-2, kindly provided
by Dr. F. Fitch, University of Chicago, Chicago, IL.
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University of Massachusetts Medical School, Worcester, MA, and belong to
the Th2 subset of helper/inducer T cells (IL-4 producers) (6, 13). DIA and D1 .6 were
generated in our own laboratory and belong to the Thl subset of helper/inducer T cells
(IFN-,y, IL-2 producers) (6). CDC35, DIA, and D1.6 are I-A
d restricted, and CDC25 is
I-A('
Xd)F, restricted. Clones were maintained by weekly stimulation with irradiated spleen
cells and antigen, as described (6). Spleen cellswere isolated from BALB/c (for CDC35,
Dl .l,, DI .6) and (BALB/c X A/J) F, (CAFI) mice (for CDC25).8-12-wk-old mice were
purchased from The Jackson Laboratory, Bar Harbor, ME, and maintained in accor-
dance with guidelines of the Committee on Animals of the Harvard Medical School and
those prepared by the Committee on Care and Use of Laboratory Animals of the Insti-
tute of Laboratory Animal Resources, National Research Council (DHEW publication
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To assure that mitomycin C treatment had inhibited proliferation, T cells were cultured
with 100 U of IL-2 in each experiment and shown to not incorporate [sH]thymidine.
For measuring IL-4 and IL-2 secretion, supernatants (SN) were collected on day 1 of
culture and assayed at 50% vol/vol for stimulation of HT-2 cells in the presence and
absence of anti-IL-4 (1 :40 dilution) or anti-IL-2 (1 :20) antibodies, and previously
described (2). For assays of IFN-'y secretion, day 1 SN were assayed at 25% vol/vol for
growth inhibition of 2 X 10' WEHI-279 cells, in the absence and presence of anti-IFN-
.y antibody, as described (23). For all assays, standard curves were generated using
recombinant lymphokines present in test SN.
Purification and Culture ofB Cells.
￿
Small resting B cells were purified from the spleens
of unprimed BALE/c or CAF1 mice, according to methods described by Kreiger et al.
(24) . Spleen cells were treated with anti-Thy-1 .2, anti-Lyt-1.2, and anti-Lyt-2 for 45 min
at 4°C, followed by a 30-min incubationat 37°C in low tox rabbit complement (Cedarlane
Laboratories Ltd., Hornby, Ontario). The remaining cells were washed and placed on a
discontinuous Percoll gradient composed of 2.5 ml each of 50, 60, 65, and 72% Percoll
(Pharmacia, Uppsala, Sweden). Approximately 10' cells were placed on the
centrifuged (2,000 g) at 4°C for 12 min. Cells recovered at the 65/7
considered to be small resting B cells, corresponding to a density of 1 .081-1 .089 g/m
These cells did not respond to the anti-IgM mAb, Bet2 (1 :4 dilution of hybridoma super-
natant), of IL-4 alone, but did proliferate when Bet2 and IL-4 were present in a co-
imulation assay (25). For the experiments described under results, 10' B cells were
cultured with antigen, mitomycin C-treated T cells, LPS, or other stimuli in 0.2 ml of
RPMI 1640 supplemented with 2 MM L-glutarnine, penicillin, streptomycin, nonessential
amino acids, sodium pyruvate, 10 mM Hepes, 5 X 10-5 M 2-ME and 10% heat-inacti-
vated FCS in flat-bottomed microculture plates at 37°C in 5% CO2. In addition, all exper-
controis: B cells alone, and B cells with IL-2 or Con A to
measure residual T cell contamination. No lymphokine secretion or proliferation was
detected in these groups (not shown).
Assaysfor B Cell Activation.
￿
For all experiments with resting B cells, two parallel sets
of cultures were established. The first was used to measure B cell proliferation and lym-
phokine secretion. Supernatants (50 Al) were harvested after 24 h in all experiments for
lymphokine assays, as described above, to demonstrate that the mitomycin C-treated T
cells had been activated. Cultures were pulsed for 6 h with I jCi [sH]thymidine per well
on day 3, harvested in a PHD cell harvester, and incorporated radioactivi
by scintillation counting. The second set of cultures was used to measure IgM, IgGI, an
IgG2a and in the SN, by an ELISA. In brief, flexible microtiter plates were coated over-
night at 4'C with polyvalent goat anti-mouse Ig (5 Ag/ml) (Southern Biotechnology Asso-
ciates, Inc., Birmingham, AL), washed and blocked with 1% BSA (Sigma Chemical Co.)
in PBS (pH 7 .2). Culture supernatants were added to microtiter wells for 4 h at room
temperature and washed. The presence of IgM, IgGI, and IgG2a was detected after
incubation with alkaline phosphatase-labeled affinity-purified goat anti-mouse antibod-
ies specific for each isotype (Southern Biotechnology Associates, Inc.), the addition of
substrate 0-nitrophenyl phosphate-disodium; (Sigma Chemical Co.), and measurement of
the optical density at 405 nm. 4-day SN were used for IgM and IgGI measurement, at
a 1 :4 dilution, and 7-d SN were used for IgG2a measurement at a 1 :2 dilution. Standard
curves were obtained for each experiment with purified myeloma proteins of known iso-
types (ICN, Lisle, IL), which were run in parallel. Results are expressed as the mean
nanograms/milliliter of antibody present in SN of duplicate cultures. There was no cross-
reaction of the alkaline phosphatase-labeled affinity-purified goat antibodies with the
propriate myeloma proteins in the 10,000 to 0.1 ng/ml range. Positive control cul-
for IgM, IgG, and IgG2a secretion were B cells incubated with LPS, LPS -1- Il.-4
(100 U/ml), and LPS -}- IFN--t (10 U/ml), respectively (17).
Results
Presentation of RAMG by Small Resting B Cells to RGti-specific Thl and Th2
Clones.
￿
Initial studies were aimed at establishing the feasibility of our experi-BOOM ET AL .
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FIGURE 1 .
￿
Presentation of antigen by B cells to Thl andTh2 clones . B cells (105)(-) or
2,500 rad irradiated spleen cells (106) (- - -) were cultured in duplicate with mitomycin C-
treated T cells (104) and F(ab') 1 RAMG (0) or F(ab') z RGG (o) . BALB/c B cells were used for
CDC35, D1 .1, and D1 .6, andCAFI B cells forCDC25 . SN were removed at 24 h and assayed
for IL-2 or IL-4 by stimulation of DNA synthesis in the HT2 indicator line . Data are
expressed as units/milliliter, using human r-IL-2 or murine rIL-4 as standards . In some
groups, SN were also tested in the presence of anti-IL2 (A) or anti-IL-4 antibody (A) to
confirm the nature of the HT2-stimulating lymphokine.
mental system for analyzing cognate T-B interactions, by determining the ability
of small resting B cells to present the model antigen, F(ab')2 RAMG, to RGG-
specific T cells. As shown in Fig . 1, both Thl (DIA and D1 .6) and Th2 (CDC25
and CDC35) cells secreted lymphokine when cultured with purified B cells and
F(ab')2 RAMG at concentrations of 0.1-1 Ag/ml . Antibody blocking confirmed
that the lymphokine measured in these assays was IL-2 or IL-4, respectively .
Moreover, both purified B cells and irradiated splenocytes presented F(ab')2
RGG at 1O3-10'-fold higher concentrations than F(ab')2 RAMG, again confirm-
ing the efficiency of Ig-mediated antigen presentation (26, 27) . Finally, only the
Thl clones secreted IFN-'Y in response to antigen presented by B cells, and the
antigen dose-response was identical to that seen for IL-2 secretion (Fig. 2) .
FIGURE 2 . IFN-y production by Thl and Th2
cells . Cell clones and B cells were cultured with
and without F(ab11 RAMG as in Fig. 1 . SN col-
lected at 24 h were assayed for IFN-y by inhibi-
tion of proliferation of WEHI279 cells ; in some
groups, anti-IFN-y antibody was also added . Data
are expressed as units/milliliter using murine
rIFN-y as the standard .1354
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FIGURE 3 .
￿
B lymphocyte proliferation induced by T cell clones: T cell dose-response. Pur-
ified B cells (10~) were cultured with and without F(ab')2 RAMG and mitomycin C-treatedT
cell clones, 10' (o), 5 X 10" (0), 20 X 10" (0), 50 X 10s (0, for CDC25) or 100 X 10'' (0,
for D1 .1). Proliferation was measured on day 3 by ["Hlthymidine incorporation.
These experiments showed that both subsets of T cells gave equivalent re-
sponses to antigen presented by purified small resting B lymphocytes. We could,
therefore, use this system for studying the activation of B cells as a consequence
of cognate interactions with Thl and Th2 clones.
Induction of B Cell Proliferation and Differentiation by Thl and Th2 Clones.
￿
To
first determine the optimal cell numbers for measuring helper function, we
examined the ability of mitocycin C-treated T cell clones to activate B cells to
proliferate in the presence of antigen. Increasing numbers (10i-105) of T cells
were added to 105 B cells with 0-1 gg/ml of F(ab')z RAMG, and proliferation
was assayed on day 3. As few as 103 Th2 cells (CDC25 and CDC35) induced
significant, antigen-dependent B cell proliferation, and 5 X 103 T cells gave
near-maximal responses. In contrast, the Thl clones induced little or no B cell
proliferation at any cell number (Fig. 3), even though lymphokine secretion was
readily detectable. Moreover, the mitomycin-treated T cells did not proliferate
in response to Con A or IL-2, and no DNA synthesis was detectable if the B
cells were also treated with mitomycin C (not shown).
Based on these results, in subsequent experiments we used 5 X 10; T cells
and 105 B cells for studying antigen-specific help. Parallel cultures were assayed
for B cell proliferation and secretion of IgM, IgGI, and IgG2a. Only the Th2
clones, CDC25 and CDC35, induced both proliferation and secretion of IgM
and IgGI (Fig. 4). The Thl clones stimulated neither B cell growth nor antibody
secretion. Moreover, neither subset of T cells was capable of eliciting an IgG2a
response, although B cells cultured with LPS and 10 U/ml of IFN--Y secreted
182 and 310 ng/ml of IgG2a in two experiments.a
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Role of Lymphokines in Th2-mediated B Cell Help.
￿
The relative contributions
of different lymphokines to Th2-mediated B cell proliferation and antibody
secretion were evaluated using neutralizing mAbs. As shown in Table I, anti-IL-
4 significantly inhibited proliferation and IgGI production, especially in the
presence of 0.1 Ag/ml of F(ab')2 RAMG, when the levels of lymphokines
secreted are lower than at higher antigen concentrations. This is consistent with
the view that IL-4 is primarily involved in proliferation of and IgGI secretion
by B cells (16) . It is noteworthy that proliferation is only partly inhibited by anti-
IL-4, suggesting that other pathways may also be operative (e.g., reference 28).
Anti-IL-4 also significantly inhibited IgM secretion, especially at RAMG concen-
trations of 0.1 /Ag/ml. Antibody to IL-5 had no effect on B cell proliferation,
but inhibited both IgM and IgGI secretion. Even more striking was the result
obtained using a combination of the two antibodies, which completely abrogated
secretion of both IgM and IgGI . These experiments demonstrate different but
1000
FIGURE 4. Induction of B lymphocyte prolifer-
800- ation and Ig secretion by T cell clones. B cells
(105) were cultured in triplicate with or without
600 - F(ab')2 RAMG and 5 X 10' mitomycin C-treated
T cells. Proliferation was measured on day 3 by
400- ['H]thymidine incorporation. SN were collected
from parallel cultures on day 4 and assayed for
200- IgM and IgGI by ELISA (2596 vol/vol). All four
T cell clones secreted lymphokine (IL-2 or IL-4),
0 and no IgG2a secretion was detected up to 7 d
0.1 1 .0 (not shown). (0) DL1, (0) D1 .6, (o) CDC25, (")
ANTIGEN CONC. (gg/ml) CDC35.1356
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TABLE I
Role of IL-4 and IL-5 in B Cell Activation by the Th2 Clone CDC35
BALB/c B cells (10) were cultured in duplicate with mitomycin C-treated CDC35 (5 X 10) and
F(ab')1RAMG. Certaincultures hadanti-IL-4, anti-IL-5, or IFN-yaddedto them. In addition, Bcells
were stimulated with LPS (10 lag/ml) alone, or with either IL-4 (100 U/ml), anti-IL-4, or anti-IL-5
added. B cell proliferation wasmeasuredon day3by ['H]thymidineincorporation. Supernatants (SN)
from parallel cultures were assayed on day 4 for IgM and IgGI secretion, by ELISA. CDC35 T cells
not added to cultures of B cellswith LPS.
complimentary roles of IL-4 and IL-5 in B cell activation, and suggest that the
helper function of Th2 cells can be attributed to these lymphokines. Moreover,
LPS-induced B cell activation was not affected by anti-IL-4 or anti-IL-5 anti-
body, demonstrating that the antibodies do not inhibit B cell responses
nonspecifically.
Finally, IFN-y, which is known to block IL-4-dependent B cell activation (29,
30), also inhibited proliferation of and IgG1 secretion by B cells in response to
antigen and Th2 cells (Table 1) . The extent of inhibition was comparable to that
observed with anti-IL-4 antibody. There was, however no IgG2a response under
these conditions. The addition of 10 U/ml of IFN--f to LPS-stimulated B cells
led to 272 ng/ml of IgG2a secretion in this experiment.
Inhibitory Effects of Thl Cells and the Role of IFN.
￿
Numerous studies have
shown that IFN-y has an antiproliferative effect on activated B lymphocytes (23,
28, 29). To determine if such inhibition was also observed in cognate T-B inter-
actions, BALB/c B cells were cultured with F(ab')z RAMG and mixtures of RGG
Antigen/
mitogen Amount Lymphokine/antibody Bcell
proliferation
Antibody secretion
IgM IgGI
Ag/ml ng/ml
- - 6,880 <20 <1
RAMG 0.1 - 53,453 824 400
1.0 - 104,224 1,952 1,126
RAMG 0.1 Anti-IL-4 (1 :10) 9,052 <20 <1
1.0 Anti-IL-4 57,929 190 48
0.1 Anti-IL-4 (1 :50) 16,953 <20 <1
1.0 Anti-IL-4 95,914 824 339
RAMG 0.1 Anti-IL-5 (1 :1,000) 42,567 <20 <1
1.0 Anti-IL-5 106,724 190 296
0.1 Anti-IL-5 (1 :5,000) 37,163 <20 <1
1.0 Anti-IL-5 102,124 965 670
Anti-IL-4 (1 :50)+
RAMG 1.0 anti-IL-5 (1 :5,000) 64,892 <20 <1
RAMG 0.1 IFN-y (10 U/ml) 20,022 <20 <1
1.0 IFN-y (10 U/m) 70,948 1,670 732
0.1 IFN-7 (100 U/ml) 13,310 <20 <1
1.0 IFN-7 (100 U/ml) 46,131 1,036 276
- 849 <20 <1
LPS 10 - 111,151 6,178 <1
LPS IL-4 (100 u/ml) 140,228 3,220 876
LPS Anti-IL-4 (1 :50) 123,297 6,741 <1
LPS Anti-IL-5 (1 :5,000) 104,696 4,698 <1
LPS Anti-IL-4 + anti-IL-5 115,112 4,769 <1BOOM ET AL .
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FIGURE 5 .
￿
Inhibition ofTh2-inducedB cell acti-
vation by Thl cells . BALB/c B cells (10) were
cultured with F(ab') 2 RAMB (1 jug/ml) and 5 X
105 mitomycin C-treated T cells, as shown, with-
out and with anti-IFN-y antibody (1 wg/ml) . Pro-
liferation and Ig secretion were measured as in
Fig . 4 . CDC35 cells did not induce proliferation
of Ig secretion in the absence of F(ab')2 RAMG,
and both clones secreted their appropriate lym-
phokines (IL-2 or IL-4) in the presence ofRAMG
(not shown).
-l- I-Ad-specific Thl and Th2 clones . As shown in Fig. 5, the Th2 clone CDC35
induced proliferation and Ig secretion . In contrast, the Thl clone Dl .l failed
to activate B cells . When both clones were added together, D1 .1 markedly inhib-
ited the two B cell responses that are most dependent on IL-4, i.e., proliferation
and IgGI secretion, and this inhibition was reversed by anti-IFN-y antibody .
These results raised the possibility that the apparent inability of Thl cells to
help B lymphocytes may be due to a dominant inhibitory effect of IFN-y . To
test this possibility, a saturating concentration of anti-IFN-y antibody was added
to cultures of B cells, antigen, and Thl clones . As shown in Table II, no prolif-
eration or antibody secretion was detected . It is also noteworthy that when the
B cells were stimulated by LPS, the addition of antigen and Thl cells did lead
to IgG2a secretion . This result is consistent with the view that IFN-y inhibits
early events in B cell activation that are induced by IL-4, but mediates a switch
to IgG2a under conditions where the inhibitory effect is not dominant (e.g ., in
LPS-stimulated cultures) .
Bystander Help by Thl and Th2 Cells.
￿
Finally, we considered the possibility
that Thl and Th2 cells may differ in their ability to help B cells in cognate inter-1358
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TABLE II
Inhibition of IFN-y Does Not Restore Helper Function of Dl .l (TH-1)forResting B Cells
BALB/c B cells (105) were cultured in duplicate with mitomycin C-treated 131.1 (5 X 10') and
F(ab')2RAMG. Certaincultures hadeither anti-IFN-y (0 .1,0.3, or 1 jug/ml) or ITS (10 Ag/ml) added
to them. In addition, B cells were stimulated with LPS alone, or ITS with either IL-4 (100 U/ml) or
IFN-y (10 U/ml) added. B cell proliferation wasmeasured on day 3. Supernatants from parallel cul-
tures were assayed on day 4 for IgM and IgGI, and on day 7 for IgG2a secretion, by ELISA. All
concentrations of anti-IFN-y completely neutralized the IFN-y secreted by 131.1 cells cultured with
B cells and RAMG.
actions as opposed to bystander cells, which are stimulated only by secreted lym-
phokines. To test this, mixtures of A/J(H-2a) and mitomycin C-treated BALB/
c (H-2d) small resting B cells were stimulated with F(ab')z RAMG and RGG +
I-Ad-specific Thl and Th2 clones. Only the Th2 clone, CDC35, induced prolif-
eration of and antibody secretion by the bystander B cells (Table III). Controls
showed that neither the A/J(I-Ak) nor the mitomycin C-treated BALB/c B cells
cultured separately could be activated under these conditions.
Discussion
Despite a vast amount of work, the requirements for antigen-specific, helper
T cell-dependent activation of B lymphocytes remain poorly defined. Thus,
many cytokines, including IL-1, IL-2, IFN-'y, IL-4, and IL-5, have been shown
to influence B cell growth and/or differentiation in vitro (9-11, 16-18), but the
critical question of which are obligatory for antibody responses to low (physio-
logic) concentrations of protein antigens is not yet resolved. The recent identi-
fication if la-restricted helper T cell subsets that differ in lymphokine secretion
profiles, and the development of neutralizing antibodies specific for lympho-
kines, provide two approaches for addressing this question. In the studies
described in this paper, we have used both approaches to analyze the activation
of resting B lymphocytes by la-restricted T cells. In particular, we have com-
pared the helper functions of a panel of T cell clones with the same antigenic
specificity but belonging to the Thl and Th2 subsets. Several aspects of the
experimental system used in these studies are noteworthy. First, we have used
unselected small, resting B cells and anti-Ig as a model antigen, so that activation
T cells Antigen/mitogen
(wg/ml)
Lymphokine/
antibody
(Ag/ml)
Bcell
proliferation
Antibody secretion
IgM I9GI IgG2a
cpm ng/ml
- - 489 <20 <l <0.1
LPS(10) - 73,599 7,800 <1 <0.1
ITS IL-4 105,593 3.872 640 <0.1
ITS IFN-y 67,265 6,560 <1 49
D1 .1 - - 1.471 <20 <1 <0.1
RAMG (0.1) - 2,294 <20 <1 <0.1
(1 .0) - 4,278 <20 <l <0.1
(1 .0) Anti-IFN-y (0 .1) 3,356 <20 <I <0.1
(1 .0) (0.3) 2,858 <20 <I <0.1
(1 .0) (1.0) 3,301 <20 <l <0.1
RAMG (1 .0) + LPS - 64,679 1,391 <1 26T cells
BOOM ET AL.
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TABLE III
Bystander Help 6y ThI and Th2 Cells
Antibody
D1 .1 (ThI)
CDC35 (Th2)
MitomycinC-treatedT cells (5 X 10") were cultured with either BALB/c,A/J, mitomycinC-treated
BALB/c, or A/J + Mitomycin C-treated BALB/c B cells (105) and 1 gg/ml of F(ab')2 RAMG. B cell
proliferationand Ig secretion were measured as in Table I. D1.1 . cells secreted > 60 U/ml IL-2 in
response to RAMG anduntreated or mitomycin C-treatedBALB/c B cells.
of the maximum possible number of cells can be assayed without the bias
imposed by affinity purification and variations in the avidity of antigen-receptor
interactions (13, 14). Second, we have assayed the same or parallel cultures for
stimulation of the helper T cell clones (by measuring IL-2 or IL-4 secretion) and
for different aspects of the B cell response (proliferation and antibody produc-
tion). Finally, we have measured the secretion of three different antibody iso-
types, IgM, IgGI, and IgG2a, whose production may depend on different lym-
phokines (17).
The major conclusion from these studies is that Th2 clones (CDC25 and
CDC35) induce both proliferation of and IgM and IgGI secretion by resting B
cells. Th2 cells stimulate B lymphocytes that they interact with directly as well
as bystander B cells. In contrast, Thl clones of the same specificity (D1.1 . and
D1 .6) fail to activate B cells in any of the assays used (Figs. 3 and 4, Table III) .
In fact, IFN-y produced by Thl cells inhibits B cell activation, its major effect
being on the IL-4-dependent responses, i.e., proliferation and IgGI secretion
(Fig. 5). The failure of Thl cells to help resting B lymphocytes cannot, however,
be attributed to a dominant inhibitory effect of IFN-y, since helper function
cannot be restored to Thl cells by the addition of anti-IFN-y antibody (Table
II). These results indicate that Thl cells do not produce the factors necessary
for activating resting B lymphocytes, and that neither IL-2 nor IFN-'Y is oblig-
atory for such responses. Such a conclusion contradicts a number of earlier
studies showing that IL-2 and IFN-y are important helper factors for B cells (9-
12). Many of these earlier studies used erythrocytes as antigens (9, 12), and it is
possible that this represents a unique situation that cannot be extrapolated to
soluble proteins. Moreover, we and others have shown that Thl cells (and their
secreted mediators) can help previously activated B cells (23) or B cells stimu-
B cells F(ab')2
RAMG
B cell
proliferation
secretion
IgM IgGi
cpm ng/ml
BALB/c - 1,148 <20 <1
+ 26,858 <20 <1
A/J + 926 <20 <1
mitomycin C BALB/c + 1,523 <20 <1
A/J + mitocycin C BALB/c + 4,275 <20 <1
BALB/c - 10,478 <20 <1
+ 123,986 3,599 270
A/J + 1,179 <20 <1
mitocycin C BALB/c + 7,080 <20 <1
A/J + mitomycin C BALB/c + 102,872 1,808 4861360
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lated polyclonally in the presence of high concentrations of antigen (4), partic-
ularly if the inhibitory effect of IFN-y is neutralized. This suggests that different
mechanisms may lead to stimulation of resting and activated B cells, and studies
are currently under way to formally address this possibility.
The stimulation of resting B cells by Th2 clones is dependent on both IL-4
and IL-5 . Thus, antibody inhibition experiments indicate that IL-4 is the major
lymphokine involved in IgGI secretion and plays a role in proliferation,
although other mechanisms may also contribute to increased DNA synthesis
(30). On the other hand, IL-5 is not a growth factor for B cells under these
conditions, but is necessary for maximal IgM production and may also contrib-
ute to the IgGI response (Table I). The observation that combinations of the
two antibodies completely inhibit differentiation of resting B cells indicates that
cognate help mediated by Th2 cells can be attributed to these two lymphokines.
Despite the potent helper activity of the Th2 clones, these cells are incapable
of inducing IgG2a responses. Controls done in parallel using polyclonally (LPS)
stimulated B cells confirmed the findings of Snapper and Paul (17) that IFN-'r
is both necessary and sufficient for the switch to IgG2a. Thus, IFN-y has two
opposing effects: it partially inhibits B cell proliferation and production of some
antibody isotypes (most notably IgGl), but is required for the secretion of
IgG2a. This raises the obvious question of how IgG2a responses are induced in
physiologic situations, especially when both subsets are likely to be activated. It
is possible that the production of this isotype may require a balance between IL-
4 and IFN-y, such that high concentrations of IL-4 may override the inhibitory
influence of IFN-y and initiate responses that culminate in B cell proliferation
and secretion of all Ig isotypes when both Thl and Th2 cells are present and
activated. Alternatively, IgG2a secretion may depend on sequential stimulation
of B cells, first with a Th2 helper cell that will induce clonal proliferation and
IgM and IgGI, and subsequently with a Thl cell that will selectively mediate the
switch to IgG2a. We are currently testing these possibilities using the panel of
clones and recombinant lymphokines described above .
Finally, we have also shown that both Thl and Th2 clones respond maximally
to antigen presented by highly purified B cells, as measured by lymphokine
secretion (Fig. 1) . Moreover, B cells present ligands that bind to their Ig recep-
tors at much lower concentrations than antigens taken up by receptor-indepen-
dent pathways or antigens presented by irradiated splenocytes (26), and this is
true for both subsets of T cells. Thus, at least in the short-term stimulation
assays used in these experiments, Thl and Th2 subsets do not respond prefer-
entially to antigen presented by different presenting cells (B cells or irradiated
whole splenocytes). One might predict that the most efficient APC for Thl cells
are macrophages, since IFN-y induces la expression on macrophages, and for
Th2 clones are B cells, since IL-4 enhances B cell la expression. This may occur
under limiting conditions, but is clearly not the case at the cell numbers and
antigen concentrations that we have used. It is also possible that different T cell
subsets vary in proliferative responses to antigen presented by different acces-
sory cells, and this reflects the requirement for costimulators such as IL-1 . Thus,
it is known that Th2 cells are IL-1 sensitive whereas Thl cells are not (6). To
what extent the activation, proliferation, and function of Thl and Th2 cells areBOOM ET AL.
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dependent on selective pressures imposed by different APCs is a question that
remains to be resolved.
Summary
To compare the helper function of murine T cell clones that secrete IL-2 and
IFN-y (Thl cells) or IL-4 and IL-5 (Th2), purified resting B cells were stimu-
lated with F(ab')2 rabbit anti-mouse Ig (RAMG) and rabbit Ig-specific, class II
MHC-restricted cloned T cells belonging to the two subsets. Both Th2 clones
examined induced strong proliferative responses of B cells in the presence of
RAMG, as well as the secretion of IgM and IgGI antibodies. In contrast, the
Thl clones tested failed to stimulate B cell growth or antibody secretion. Th2-
mediated B cell activation was dependent on IL-4 and IL-5, and was also inhib-
ited by IFN-y or IFN-y produced by Thl cells present in the same cultures.
However, the failure of Thl cells to help resting B cells could not be reversed
with neutralizing anti-IFN-y antibody. In addition to this inhibitory effect, IFN-
y was required for the secretion of IgG2a antibody, particularly when B cells
were stimulated with polyclonal activators such as LPS. Finally, both sets of T
cell clones secreted lymphokines when stimulated with purified B cells and
RAMG. These experiments demonstrate that T cells that differ in lymphokine
production also differ in their ability to help B cells as a result of cognate inter-
actions at low concentrations of antigens. Moreover, IL-4, IL-5, and IFN-y
serve different roles in the T cell-dependent proliferative and differentiative
responses of resting B lymphocytes.
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